2 completed. .
Follow Nicola Irwin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory Respiratory Syncytial Virus (RSV) Infection, Respiratory Syncytial Virus Hospitalizations | Completed | Nicola Irwin | 2792 | 2025-09-22 | 2026-03-05 | |
| First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory Respiratory Syncytial Viral (RSV) Infection, Respiratory Syncytial Virus Hospitalizations | Completed | Nicola Irwin | 2355 | 2024-12-01 | 2025-09-19 |
Infections (2)
Australia (2)